Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

A US drug company says it has created the first therapy that could slow Alzheimer's disease, and it is now ready to bring it to market. Currently, there are no drugs that can do this - existing ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

These treatments are only effective for people with Alzheimer’s disease ... Donepezil tablets are by far the most common medication used to treat dementia. Rivastigmine tends only to be used when ...

The UK's drugs watchdog has started assessing it for possible NHS use. The drug works in Alzheimer's disease, not in other types of dementia ... donanemab trial. For most, this resolved without ...